PlumX Metrics
Embed PlumX Metrics

Application of Homograft Valved Conduit in Cardiac Surgery

Frontiers in Cardiovascular Medicine, ISSN: 2297-055X, Vol: 8, Page: 740871
2021
  • 12
    Citations
  • 0
    Usage
  • 18
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    12
    • Citation Indexes
      12
  • Captures
    18
  • Mentions
    1
    • News Mentions
      1
      • News
        1

Most Recent News

Homograft Replacement Twenty-Four Years After Persistent Truncus Arteriosus Repair

This video demonstrates a redo aortic root procedure and homograft replacement for a thirty-year-old woman who was diagnosed with PTA at birth. She also had

Review Description

Valved conduits often correct the blood flow of congenital heart disease by connecting the right ventricle to the pulmonary artery (RV-PA). The homograft valved conduit was invented in the 1960s, but its wide application is limited due to the lack of effective sterilization and preservation methods. Modern cryopreservation prolongs the preservation time of homograft valved conduit, which makes it become the most important treatment at present, and is widely used in Ross and other operations. However, homograft valved conduit has limited biocompatibility and durability and lacks any additional growth capacity. Therefore, decellularized valved conduit has been proposed as an effective improved method, which can reduce immune response and calcification, and has potential growth ability. In addition, as a possible substitute, commercial xenograft valved conduit has certain advantages in clinical application, and tissue engineering artificial valved conduit needs to be further studied.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know